AI Summary
The board of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) recommended, on April 3, a 15% cash dividend, or SAR 1.5 per share, for the second half of 2023, the company said in a statement to Tadawul.
|
Dividend Details (H2 2023) |
|
|
Current capital |
SAR 700 mln |
|
Number of shares |
70 mln |
|
Dividend |
SAR 105 mln |
|
Percentage of capital |
15% (SAR 1.5 per share) |
|
Record date |
Shareholders of record and those registered with Edaa by the close of the second trading day following the record date |
|
Payment date |
To be set later |
|
2023 Dividends |
|
|
Total dividend |
SAR 175 mln |
|
Percentage of capital |
25% (SAR 2.5 per share) |
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 04/04/2024 | 04/06/2024 | 13/06/2024 | 105.00 | 1.50 | |
| 10/08/2023 | 20/08/2023 | 03/09/2023 | 70.00 | 1.00 |
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | N/A | N/A | N/A |
| Last 5 Financial years | N/A | N/A | N/A |
| Last 10 Financial years | N/A | N/A | N/A |
| P/E (TTM) | 20.87 |
| P/E Before Unusual Items (TTM) | 20.87 |
| P/BV | 5.65 |
| Dividend Yield | 2.01 % |
| Market Cap. (M) | 9,338.01 |
| Return on Average Assets | 22.92 % |
| Return on Average Equity | 28.89 % |
Be the first to comment
Comments Analysis: